Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$8.48 - $11.13 $38,575 - $50,630
-4,549 Reduced 20.64%
17,495 $149,000
Q2 2022

Aug 11, 2022

SELL
$9.95 - $12.27 $11,979 - $14,773
-1,204 Reduced 5.18%
22,044 $231,000
Q1 2022

May 09, 2022

SELL
$9.81 - $15.4 $45,057 - $70,732
-4,593 Reduced 16.5%
23,248 $253,000
Q4 2021

Feb 10, 2022

SELL
$12.09 - $14.68 $34,021 - $41,309
-2,814 Reduced 9.18%
27,841 $377,000
Q3 2021

Nov 10, 2021

SELL
$13.25 - $15.13 $59,717 - $68,190
-4,507 Reduced 12.82%
30,655 $415,000
Q2 2021

Aug 09, 2021

SELL
$12.97 - $16.15 $28,585 - $35,594
-2,204 Reduced 5.9%
35,162 $502,000
Q1 2021

May 10, 2021

SELL
$13.59 - $18.54 $60,434 - $82,447
-4,447 Reduced 10.64%
37,366 $522,000
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $597,925 - $783,575
41,813 New
41,813 $784,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Marble Harbor Investment Counsel, LLC Portfolio

Follow Marble Harbor Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marble Harbor Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marble Harbor Investment Counsel, LLC with notifications on news.